Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva
Authors:
- H.W.A. de BruijnHBH.W.A. de Bruijn
- 30 November 1989
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 35 (2) , 227-232
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Production of Tumor-Associated Antigen, TA-4, by the CaSki Cervical Carcinoma Cell LineObstetrics & Gynecology, 1986
- Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimensCancer, 1986
- Immunocytological Distribution of the Tumor AntigenAsia-Oceania Journal of Obstetrics and Gynaecology, 1986
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinomaCancer, 1984
- Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancerCancer, 1982
- Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progressCancer, 1979
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinomaCancer, 1977